NOVAVAX INC
NVAX
19 insider filings · Latest: Apr 25, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | May 7 9:03 PM | Ruxandra Draghia Akli | Proposed Sale | 30,000 | $9.87 | $296.1K | — | View → |
| May 19, 2025 | May 19 8:37 PM | YOUNG JAMES F | Proposed Sale | 10,000 | $7.59 | $75.9K | — | View → |
| Apr 14, 2025 | Apr 14 8:19 PM | YOUNG JAMES F | Proposed Sale | 4,000 | $6.10 | $24.4K | — | View → |
| Dec 24, 2024 | Jan 2 9:02 PM | YOUNG JAMES F | Proposed Sale | 10,000 | $8.48 | $84.8K | — | View → |
| Dec 24, 2024 | Dec 26 3:31 PM | YOUNG JAMES F | Proposed Sale | 10,000 | $8.48 | $84.8K | — | View → |
| Dec 13, 2024 | Dec 13 5:13 PM | Rachel K. King | Proposed Sale | 4,150 | $9.00 | $37.4K | — | View → |
| Sep 18, 2024 | Sep 18 8:08 PM | Dubovsky Filip | Proposed Sale | 7,335 | $13.00 | $95.3K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 25, 2026 | Apr 28 9:00 PM | Charles W. NewtonDirector | Option Exercise | 9,520 | — | 19,040(D) | View → |
| Apr 14, 2026 | Apr 16 10:13 PM | Robert Edward WalkerEVP, R&D | Grant/Award | 165,500 | $8.46 | 6,600(D) | View → |
| Mar 10, 2026 | Mar 12 9:00 PM | John W. ShiverDirector | Option Exercise | 7,947 | $0.00 | 15,893(D) | View → |
| Mar 7, 2026 | Mar 9 10:13 PM | James Patrick KellyEVP, CFO and Treasurer | Option Exercise | 12,223 | $0.00 | 0(D) | View → |
| Mar 2, 2026 | Mar 9 10:12 PM | James Patrick KellyEVP, CFO and Treasurer | Grant/Award | 194,000 | — | 194,000(D) | View → |
| Mar 2, 2026 | Mar 9 10:11 PM | Ruxandra Draghia-AkliEVP, Research & Development | Grant/Award | 139,500 | — | 139,500(D) | View → |
| Mar 2, 2026 | Mar 9 10:09 PM | Mark J CaseyEVP, Chief Legal Officer | Grant/Award | 152,000 | — | 152,000(D) | View → |
| Mar 2, 2026 | Mar 9 10:08 PM | John C JacobsDirector, President and CEO | Grant/Award | 551,500 | — | 551,500(D) | View → |
| Mar 2, 2026 | Mar 9 10:06 PM | Elaine O'HaraEVP, Chief Strategy Officer | Grant/Award | 177,500 | — | 177,500(D) | View → |
| Mar 3, 2026 | Mar 5 11:04 AM | James Patrick KellyEVP, CFO and Treasurer | Option Exercise | 43,167 | $0.00 | 86,333(D) | View → |
| Mar 3, 2026 | Mar 5 11:03 AM | John C JacobsDirector, President and CEO | Option Exercise | 150,167 | $0.00 | 300,333(D) | View → |
| Mar 3, 2026 | Mar 5 11:02 AM | Elaine O'HaraEVP, Chief Strategy Officer | Option Exercise | 56,334 | $0.00 | 112,666(D) | View → |
| Mar 3, 2026 | Mar 5 11:01 AM | Mark J CaseyEVP, Chief Legal Officer | Option Exercise | 4,000 | $0.00 | 4,000(D) | View → |
| Mar 3, 2026 | Mar 5 11:00 AM | Ruxandra Draghia-AkliEVP, Research & Development | Disposition | 26,667 | $0.00 | 53,333(D) | View → |
| Mar 2, 2026 | Mar 5 11:00 AM | Ruxandra Draghia-AkliEVP, Research & Development | Grant/Award | 232,500 | $9.09 | 139,500(D) | View → |
| Mar 2, 2026 | Mar 4 2:37 AM | John C JacobsDirector, President and CEO | Grant/Award | 919,000 | $9.09 | 551,500(D) | View → |
| Mar 1, 2026 | Mar 4 2:37 AM | John C JacobsDirector, President and CEO | Option Exercise | 83,333 | $0.00 | 0(D) | View → |
| Mar 2, 2026 | Mar 4 2:35 AM | James Patrick KellyEVP, CFO and Treasurer | Grant/Award | 323,500 | $9.09 | 194,000(D) | View → |
| Mar 1, 2026 | Mar 4 2:35 AM | James Patrick KellyEVP, CFO and Treasurer | Disposition | 58,666 | $0.00 | 58,666(D) | View → |
| Mar 2, 2026 | Mar 4 2:34 AM | Elaine O'HaraEVP, Chief Strategy Officer | Grant/Award | 295,500 | $9.09 | 177,500(D) | View → |
Page 1 of 2
Next →